New York-based AI biotechnology company Paige entered into a collaboration with pathology digitization company OptraSCAN to accelerate the adoption of digital pathology across key markets, including the US, the UK, and Europe. The terms and financial details of the partnership have not been disclosed.
The partnership will combine Paige’s AI-powered platform and solutions with OptraSCAN’s digital pathology scanner to provide efficient workflow solutions for pathologists to leverage Paige’s digital pathology and AI applications.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.